Skip to main content
. 2021 May 17;116(8):1587–1600. doi: 10.14309/ajg.0000000000001266

Table 4.

Efficacy and safety of antispasmodics for abdominal pain in studies of non-IBS functional GI disorders

graphic file with name acg-116-1587-g006.jpg